0 Bewertungen

ID

13997

Beschreibung

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01546038

Link

https://clinicaltrials.gov/show/NCT01546038

Stichworte

  1. 21.03.16 21.03.16 -
Hochgeladen am

21. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Acute Myeloid Leukemia NCT01546038

    Eligibility Acute Myeloid Leukemia NCT01546038

    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    Patients with aml or raeb 2 high risk mds who are newly diagnosed according to the who 2008 classification and previously untreated.
    Beschreibung

    Acute Myelocytic Leukemia

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023467 (Leukemia, Myelocytic, Acute)
    SNOMED
    17788007
    Patients with aml (arising from an antecedent hematologic disease [ahd]) or mds who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. the patients may not have had a prior therapy for their aml.
    Beschreibung

    MDS

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C3463824 (MYELODYSPLASTIC SYNDROME)
    SNOMED
    109995007
    aml patients include de novo aml, aml evolving from mds or other ahd and aml after previous cytotoxic therapy or radiation (secondary aml)
    Beschreibung

    Therapy-related acute myeloid leukemia and myelodysplastic syndrome

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1292776 (Therapy-related acute myeloid leukemia and myelodysplastic syndrome)
    SNOMED
    721306009
    For a diagnosis of aml, a bone marrow blast count of 20% or more is required.
    Beschreibung

    Leukemic Blast Count

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C2697913 (Leukemic Blast Count)
    For a diagnosis of high-risk myelodysplastic syndrome raeb 2 the patient must have 10-19% bone marrow blasts
    Beschreibung

    Bone marrow blasts

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1982687 (undefined)
    Adequate organ function
    Beschreibung

    Organ function

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1254358 (Organ or Tissue Function)
    ecog performance status 0, 1, or 2
    Beschreibung

    ECOG

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1520224 (ECOG performance status)
    SNOMED
    423740007
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    aml m3 acute promyelocytic leukemia (apl) or patients with a t(9:22) cytogenetic translocation.
    Beschreibung

    Acute Promyelocytic Leukemia

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023487 (Acute Promyelocytic Leukemia)
    SNOMED
    110004001
    patients with known active uncontrolled central nervous system (cns) leukemia.
    Beschreibung

    Central nervous system leukaemia

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1332884 (Central nervous system leukaemia)

    Ähnliche Modelle

    Eligibility Acute Myeloid Leukemia NCT01546038

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Acute Myelocytic Leukemia
    Item
    Patients with aml or raeb 2 high risk mds who are newly diagnosed according to the who 2008 classification and previously untreated.
    boolean
    C0023467 (UMLS CUI [1])
    MDS
    Item
    Patients with aml (arising from an antecedent hematologic disease [ahd]) or mds who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. the patients may not have had a prior therapy for their aml.
    boolean
    C3463824 (UMLS CUI [1])
    Therapy-related acute myeloid leukemia and myelodysplastic syndrome
    Item
    aml patients include de novo aml, aml evolving from mds or other ahd and aml after previous cytotoxic therapy or radiation (secondary aml)
    boolean
    C1292776 (UMLS CUI [1])
    Leukemic Blast Count
    Item
    For a diagnosis of aml, a bone marrow blast count of 20% or more is required.
    boolean
    C2697913 (UMLS CUI [1])
    Bone marrow blasts
    Item
    For a diagnosis of high-risk myelodysplastic syndrome raeb 2 the patient must have 10-19% bone marrow blasts
    boolean
    C1982687 (UMLS CUI [1])
    Organ function
    Item
    Adequate organ function
    boolean
    C1254358 (UMLS CUI [1])
    ECOG
    Item
    ecog performance status 0, 1, or 2
    boolean
    C1520224 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Acute Promyelocytic Leukemia
    Item
    aml m3 acute promyelocytic leukemia (apl) or patients with a t(9:22) cytogenetic translocation.
    boolean
    C0023487 (UMLS CUI [1])
    Central nervous system leukaemia
    Item
    patients with known active uncontrolled central nervous system (cns) leukemia.
    boolean
    C1332884 (UMLS CUI [1])

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video